Disclaimers:

“This webinar is intended for Healthcare Professionals in UAE only”

To report Adverse Event/s associated with the use of GSK product/s, please contact us via gulf.safety@gsk.com

To report quality complaint/s associated with the use of GSK product/s, please contact us via Gulf.ProductQualityComplaints@gsk.com

For more information, please refer to the prescribing information or contact GlaxoSmithKline via gcc.medinfo@gsk.com

Privacy Statement:
GSK may process personal information about you when you participate in GSK webcasts. For more information, please read our privacy statement.
Terms of use        Privacy statement

Copyrights statement: ©2026 GSK group of companies or its licensor. All rights reserved.

Trademarks are owned by or licensed to the GSK group of companies.

GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.

Cl Ref. NX-AE-GVU-WCNT-260001 – January 2026